These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22287766)

  • 21. [Advanced sarcomatoid renal cell carcinoma effectively treated with sunitinib: report of a case].
    Tsuchiyama K; Ito H; Ishida H; Itoh H; Yokoyama O
    Hinyokika Kiyo; 2011 Nov; 57(11):615-8. PubMed ID: 22166824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.
    Bojic M; Schmidinger M
    Clin Genitourin Cancer; 2012 Dec; 10(4):277-9. PubMed ID: 22658385
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety.
    Uemura H; Shinohara N; Yuasa T; Tomita Y; Fujimoto H; Niwakawa M; Mugiya S; Miki T; Nonomura N; Takahashi M; Hasegawa Y; Agata N; Houk B; Naito S; Akaza H
    Jpn J Clin Oncol; 2010 Mar; 40(3):194-202. PubMed ID: 19897852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sunitinib for metastatic renal cell carcinoma.
    Mukherji D; Larkin J; Pickering L
    Future Oncol; 2010 Sep; 6(9):1377-85. PubMed ID: 20919823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.
    Tamaskar I; Garcia JA; Elson P; Wood L; Mekhail T; Dreicer R; Rini BI; Bukowski RM
    J Urol; 2008 Jan; 179(1):81-6; discussion 86. PubMed ID: 17997441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma.
    Elfiky AA; Cho DC; McDermott DF; Rosenberg JE; Fortner B; Antràs L; Chen K; Sheng Duh M; Jayawant SS; Oh WK; Atkins MB; Choueiri TK
    Urol Oncol; 2011; 29(6):756-63. PubMed ID: 20451414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinoma.
    Ayllon J; Beuselinck B; Morel A; Barrascout E; Medioni J; Scotte F; Oudard S
    Cancer Invest; 2011 May; 29(4):282-5. PubMed ID: 21469976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α.
    Tsimafeyeu I; Zart JS; Chung B
    BJU Int; 2013 Jul; 112(1):32-8. PubMed ID: 23746142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer.
    Powles T; Kayani I; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boletti K; Sadev A; O'Brien T; Berney D; Beltran L; Haanen J; Bex A
    Ann Oncol; 2011 May; 22(5):1041-1047. PubMed ID: 21242586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.
    Narayanan S; Callis-Duffin K; Batten J; Agarwal N
    Am J Med Sci; 2010 Jun; 339(6):580-1. PubMed ID: 20421784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report.
    Sbitti Y; Debbagh A; Slimani K; Mahi M; Errihani H; Ichou M
    J Med Case Rep; 2018 Mar; 12(1):80. PubMed ID: 29554941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].
    Komeya M; Matsumoto T; Fujinami K; Senga Y; Asakura T; Goto A
    Hinyokika Kiyo; 2010 Sep; 56(9):499-503. PubMed ID: 20940524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged response to cytoreductive surgery and sunitinib in an elderly patient with synchronous multiple metastases from renal cell carcinoma.
    Locatelli MC; Miedico A; D'Antona A; Longo G; Maggioni M; Maggioni A; Tombolini P; Tabiadon D
    Tumori; 2010; 96(3):478-82. PubMed ID: 20845812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of Sunitinib in the treatment of metastatic renal clear cell carcinoma: a single center 23 cases experience].
    Li XS; Song Y; Gong K; Zhang Q; Yu W; Song G; Zhao Z; Zhang Z; Wang G; Zhou LQ; He ZS; Jin J
    Zhonghua Wai Ke Za Zhi; 2010 Mar; 48(5):375-7. PubMed ID: 20450612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function.
    Maita S; Yuasa T; Tsuchiya N; Mitobe Y; Narita S; Horikawa Y; Hatake K; Fukui I; Kimura S; Maekawa T; Habuchi T
    Int J Cancer; 2012 Feb; 130(3):677-84. PubMed ID: 21387300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic renal clear cell carcinoma to the rectum, lungs, ilium, and lymph nodes: A case report.
    Zheng G; Li H; Li J; Zhang X; Zhang Y; Wu X
    Medicine (Baltimore); 2017 Jan; 96(1):e5720. PubMed ID: 28072710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metastasis to the Tongue from Renal Cell Carcinoma 10 Years after Nephrectomy : A Case Report].
    Wang C; Takeda K; Shiba M; Takayama H; Munakata S
    Hinyokika Kiyo; 2016 Aug; 62(8):407-10. PubMed ID: 27624106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma.
    Revheim ME; Winge-Main AK; Hagen G; Fjeld JG; Fosså SD; Lilleby W
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):339-43. PubMed ID: 21134733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: a retrospective analysis.
    Medioni J; Choueiri TK; Zinzindohoué F; Cho D; Fournier L; Oudard S
    J Urol; 2009 Jun; 181(6):2470-5; discussion 2475. PubMed ID: 19371877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of patients with renal cell carcinoma metastatic to the brain treated with sunitinib without local therapy.
    Lim ZD; Mahajan A; Weinberg J; Tannir NM
    Am J Clin Oncol; 2013 Jun; 36(3):258-60. PubMed ID: 22441343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.